BioSpace News Archive

Drug Development

Recida Therapeutics Announces the Initiation of a Phase I Clinical Trial of RC-01, a Novel LpxC Inhibitor

RC-01 represents a new class of antibiotics in development for the treatment of serious antibiotic-resistant infections

April 1, 2019
·
2 min read
Business

Resolution Liquid Biopsy Assay Outperforms Guardant360 in Retrospective Non-Small Cell Lung Carcinoma Comparison Pilot Study

Scientists from Dana-Farber Cancer Institute present results demonstrating detection of more actionable oncogenic fusions today at AACR Annual Meeting

April 1, 2019
·
3 min read
Biotech Beach

Turning Point Therapeutics’ Kinase Inhibitors Show High Potency against Targeted Oncogene Drivers and Their Mutations

Company Presents Four Studies at American Association for Cancer Research Annual Conference

April 1, 2019
·
8 min read
Drug Development

Peloton Therapeutics Announces Clinical Data Update for PT2977 at European International Kidney Cancer Symposium

Oral presentation highlights encouraging outcomes in patients with advanced renal cell carcinoma

April 1, 2019
·
3 min read
Business

Brian Tyler Becomes McKesson’s New CEO

Edward Mueller assumes role as independent chair of McKesson’s Board of Directors

April 1, 2019
·
3 min read
Business

InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update

InVivo today reported financial results for the year ended December 31, 2018.

April 1, 2019
·
7 min read
Business

Lunit to Present Abstracts on AI-Powered Precision Pathology at AACR 2019

The meeting will be held March 29 – April 3, 2019, at the Georgia World Congress Center in Atlanta, Georgia.

April 1, 2019
·
2 min read
FDA

FDA approves the reintroduction of Zelnorm™ (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in women under 65

Zelnorm works differently than other prescription treatments for IBS-C by inducing intestinal contraction and relaxation.

April 1, 2019
·
7 min read
Biotech Beach

YGYI’s Khrysos Industries, Inks $11 Million Supply Contract for Sale and Processing of CBD Isolate Powder

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that it executed a one year Supply and Processing Agreement to produce 99% pure CBD (No THC) Isolate.

April 1, 2019
·
4 min read
Biotech Beach

HUM Nutrition introduces Pre and Probiotic Supplement formulated for acne-prone (non-cystic) and dry skin after concluding consumer study

HUM Nutrition, the leading beauty vitamin and supplement company, announces the launch of Skin Heroes, the first pre+probiotic that specifically targets the gut-skin axis, formulated for acne-prone (non-cystic) and dry skin.

April 1, 2019
·
2 min read